Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Amarin Corporation PLC
AMRNCurrent price
0.6 USD
-0.0075 USD (-1.23%)
Last closed
0.61 USD
Company
www.amarincorp.com
ISIN
US0231112063
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Capitalization
257 187 472 USD
Yield for 12 month
-41.13 %
1Y
3Y
5Y
10Y
15Y
AMRN
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Address: Iconic Offices, The Greenway, Dublin, Ireland, 112-114
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 USDP/E ratio
–Dividend Yield
–Current Year
+308 100 608 USD
Last Year
+369 193 000 USD
Current Quarter
+67 566 660 USD
Last Quarter
+56 486 727 USD
Current Year
+202 586 206 USD
Last Year
+242 484 000 USD
Current Quarter
+42 055 093 USD
Last Quarter
+31 124 218 USD
Key Figures AMRN
1 year
3 years
5 years
10 years
EBITDA
-23 790 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-2.02 %
PEG Ratio
-1.74
Return On Equity TTM
-5.98 %
Wall Street Target Price
1 USD
Revenue TTM
264 779 008 USD
Book Value
1.34 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-15.8 %
Dividend Yield
–
Gross Profit TTM
260 562 000 USD
Earnings per share
-0.09 USD
Diluted Eps TTM
-0.09 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-94.2 %
Profit Margin
-12.66 %
Dividend Analytics AMRN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AMRN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
18.01.2008
Dividend Date
–
Stock Valuation AMRN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
500
Enterprise Value Revenue
0.0756
Price Sales TTM
0.9713
Enterprise Value EBITDA
-5.8
Price Book MRQ
0.4699
Financials AMRN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AMRN
For 52 weeks
0.57 USD
1.37 USD
50 Day MA
0.7 USD
Shares Short Prior Month
18 466 056
200 Day MA
0.88 USD
Short Ratio
10.42
Shares Short
18 606 078
Short Percent
4.58 %
BeatStart